AAAAAA
Results:
1-20
|
Results: 20
Authors:
Bergquist, A
Broome, U
Citation: A. Bergquist et U. Broome, Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis, BEST PR RES, 15(4), 2001, pp. 643-656
Authors:
Manns, MP
Broome, U
Citation: Mp. Manns et U. Broome, Primary sclerosing cholangitis - Preface, BEST PR RES, 15(4), 2001, pp. VII-VII
Authors:
Bergquist, A
Glaumann, H
Stal, P
Wang, GS
Broome, U
Citation: A. Bergquist et al., Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma, J INTERN M, 249(1), 2001, pp. 69-75
Authors:
Kuper, H
Ye, WM
Broome, U
Romelsjo, A
Mucci, LA
Ekbom, A
Adami, HO
Trichopoulos, D
Nyren, O
Citation: H. Kuper et al., The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis, HEPATOLOGY, 34(4), 2001, pp. 714-718
Authors:
Leidenius, M
Hockerstedt, K
Broome, U
Ericzon, BG
Friman, S
Olausson, M
Schrumpf, E
Citation: M. Leidenius et al., Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study, J HEPATOL, 34(6), 2001, pp. 792-798
Authors:
Boberg, KM
Spurkland, A
Rocca, G
Egeland, T
Saarinen, S
Mitchell, S
Broome, U
Chapman, R
Olerup, O
Pares, A
Rosina, F
Schrumpf, E
Citation: Km. Boberg et al., The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis, SC J GASTR, 36(8), 2001, pp. 886-890
Authors:
Marschall, HU
Broome, U
Einarsson, C
Alvelius, G
Thomas, HG
Matern, S
Citation: Hu. Marschall et al., Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis, J LIPID RES, 42(5), 2001, pp. 735-742
Authors:
Bodin, K
Bretillon, L
Aden, Y
Bertilsson, L
Broome, U
Einarsson, C
Diczfalusy, U
Citation: K. Bodin et al., Antiepileptic drugs increase plasma levels of 4 beta-hydroxycholesterol inhumans - Evidence for involvement of cytochrome P450 3A4, J BIOL CHEM, 276(42), 2001, pp. 38685-38689
Authors:
Bo, X
Broome, U
Remberger, M
Sumitran-Holgersson, S
Citation: X. Bo et al., Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis, GUT, 49(1), 2001, pp. 131-141
Authors:
Lindberg, BU
Broome, U
Persson, B
Citation: Bu. Lindberg et al., Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine - Results from a 20-year surveillance study, DIS COL REC, 44(1), 2001, pp. 77-83
Authors:
Bergquist, A
Tribukait, B
Glaumann, H
Broome, U
Citation: A. Bergquist et al., Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?, J HEPATOL, 33(6), 2000, pp. 873-877
Authors:
Boberg, KM
Schrumpf, E
Bergquist, A
Broome, U
Pares, A
Remotti, H
Schjolberg, A
Spurkland, A
Clausen, OPF
Citation: Km. Boberg et al., Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development, J HEPATOL, 32(3), 2000, pp. 374-380
Authors:
Broome, U
Bergquist, A
Citation: U. Broome et A. Bergquist, Management of primary sclerosing cholangitis in adults, J HEPATOL, 32, 2000, pp. 21-22
Authors:
Saarinen, S
Olerup, O
Broome, U
Citation: S. Saarinen et al., Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis, AM J GASTRO, 95(11), 2000, pp. 3195-3199
Authors:
Palmer, U
Liu, Z
Broome, U
Klominek, J
Citation: U. Palmer et al., Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells, EUR RESP J, 14(2), 1999, pp. 405-411
Authors:
Olsson, R
Broome, U
Danielsson, A
Hagerstrand, I
Jarnerot, G
Loof, L
Prytz, H
Ryden, BO
Citation: R. Olsson et al., Spontaneous course of symptoms in primary sclerosing cholangitis: Relationships with biochemical and histological features, HEP-GASTRO, 46(25), 1999, pp. 136-141
Authors:
Hultcrantz, R
Olsson, R
Danielsson, B
Jarnerot, C
Loof, L
Ryden, BO
Wahren, B
Broome, U
Citation: R. Hultcrantz et al., A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis, J HEPATOL, 30(4), 1999, pp. 669-673
Authors:
Halasz, R
Barkholt, L
Lara, C
Hultgren, C
Ando, Y
Broome, U
Fischler, B
Nemeth, A
Ericzon, BG
Sonnerborg, A
Sallberg, M
Citation: R. Halasz et al., Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products, GUT, 44(2), 1999, pp. 274-278
Authors:
Spurkland, A
Saarinen, S
Boberg, KM
Mitchell, S
Broome, U
Caballeria, L
Ciusani, E
Chapman, R
Ercilla, G
Fausa, O
Knutsen, I
Pares, A
Rosina, F
Olerup, O
Thorsby, E
Schrumpf, E
Citation: A. Spurkland et al., HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations, TISSUE ANTI, 53(5), 1999, pp. 459-469
Authors:
Broome, U
Hultcrantz, R
Lefvert, AK
Yi, Q
Citation: U. Broome et al., Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis, DIS COL REC, 41(12), 1998, pp. 1543-1549
Risultati:
1-20
|